EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Gut microbiota–immune–metabolic crosstalk in acute lung injury: integrating the gut–lung axis from mechanism to therapeutic targeting

Wenyu Wu iD, Zhenyang Wang, Yiyan Li, Ning Luo, Rui Chen, Ruifeng Zeng, Jun Li

Seminars in Immunopathology · 10.09.2026 · 48 (1)

DOI: 10.1007/s00281-026-01081-0 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Immunopathology, online erschienen am 10.09.2026. Verfasst von Wenyu Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical school of Guangzhou University of Chinese Medicine, Guangzhou, 510405, China. wuwenyu5@163.com. Hauptthemen laut MEDLINE: Acute Lung Injury, Gastrointestinal Microbiome, Lung. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: national natural science foundation of china.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The gut is increasingly recognized as a central immunological organ that orchestrates host immune responses and modulates distant mucosal sites, particularly the respiratory tract. In critical illness, disruption of intestinal barrier integrity and microbial homeostasis facilitates the translocation of bacteria, endotoxins, and metabolites into the systemic circulation, thereby contributing to the development of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). The “gut–lung axis” has emerged as a key mechanistic framework linking intestinal dysfunction with pulmonary inflammation and immune dysregulation. Both direct and indirect effects of the gut microbiota play pivotal roles in shaping host immunity. Microbial metabolites, including short-chain fatty acids, bile acids, and tryptophan derivatives, regulate immune cell differentiation and function, particularly influencing the balance between regulatory T cells (Tregs) and T helper 17 (Th17) cells, which are critically involved in lung inflammatory responses. In addition, immune cells originating from the gut and bone marrow contribute to pulmonary immune activity, highlighting the systemic nature of gut-derived immune modulation. Conversely, alterations in lung microbiota can impact intestinal homeostasis, supporting the concept of bidirectional communication within the gut–lung axis. In this review, we comprehensively examine the pathophysiological mechanisms underlying ALI/ARDS across diverse etiological contexts from the perspective of gut–lung interactions, with a focus on immune cell dynamics and microbiota-derived metabolites. We further discuss emerging therapeutic strategies targeting the gut–lung axis, including microbiota modulation, fecal microbiota transplantation, and metabolic interventions. Elucidating these interconnected pathways may provide novel insights into the prevention and treatment of ALI/ARDS and advance the development of integrated organ support strategies in critical care medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Lung InjuryGastrointestinal MicrobiomeLungHumansAnimalsIntestinal Barrier FunctionDisease Susceptibility

Stichwörter der Autor:innen

Acute lung injuryCritical care medicineGut microbiotaGut–lung axis

Autor:innen und Institutionen

  • The First Clinical Medical school of Guangzhou University of Chinese Medicine, Guangzhou, 510405, China. wuwenyu5@163.com.
  • The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510405, China. wuwenyu5@163.com.
  • Guangdong Clinical Research Academy of Chinese Medicine, Guangzhou, 510405, China. wuwenyu5@163.com.
  • The First Clinical Medical school of Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
  • The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
  • Guangdong Clinical Research Academy of Chinese Medicine, Guangzhou, 510405, China.

ORCID-Profile: Wenyu Wu

Förderung

  • national natural science foundation of china

Zitieren

APA

Wu, W., Wang, Z., Li, Y., Luo, N., Chen, R., Zeng, R., & Li, J. (2026). Gut microbiota–immune–metabolic crosstalk in acute lung injury: integrating the gut–lung axis from mechanism to therapeutic targeting. Seminars in Immunopathology, 48(1). https://doi.org/10.1007/s00281-026-01081-0

Vancouver

Wu W, Wang Z, Li Y, Luo N, Chen R, Zeng R, et al. Gut microbiota–immune–metabolic crosstalk in acute lung injury: integrating the gut–lung axis from mechanism to therapeutic targeting. Seminars in Immunopathology. 2026;48(1). doi:10.1007/s00281-026-01081-0

BibTeX
@article{Wu2026,
  author = {Wu, Wenyu and Wang, Zhenyang and Li, Yiyan and Luo, Ning and Chen, Rui and Zeng, Ruifeng and Li, Jun},
  title = {Gut microbiota–immune–metabolic crosstalk in acute lung injury: integrating the gut–lung axis from mechanism to therapeutic targeting},
  journal = {Seminars in Immunopathology},
  year = {2026},
  volume = {48},
  number = {1},
  doi = {10.1007/s00281-026-01081-0}
}
Kostenlos starten →